VCA Specialty Update Symposium

Beyond Hand and Face Transplantation

SUNDAY 24 SEPTEMBER 2017 | 09.00 – 12.50
VCA Specialty Update Symposium

 

09.00 – 11.00 VCA Session
CHAIRS:  Gerald Brandacher, Baltimore, United States
               Emmanuel Morelon, Lyon, France

09:00                      Uterus transplantation: current status and future
                              Mats Brannstrom, Gothenburg, Sweden

09:30                      Penis transplantation: a viable option to restore form and function
                              Frank Graewe, Stellenbosch, South Africa

10:00                      Regenerative medicine and VCA - competitors or perfect couple?
                              Alexandra Iordachescu, Birmingham, United Kingdom

10:30                      Novel technologies for local skin-specific drug delivery
                              Constantin Coussios, Oxford, United Kingdom

 

11.10 – 12.50 Joint BSC and VCA Session

CHAIRS: Gerald Brandacher, Baltimore, United States
              Nina Pilat-Michalek, Vienna, Austria
             

11:10                      VCA and regenerative medicine: a perfect couple?
                              Gerald Brandacher, Baltimore, United States

11:20                      Creating stem cell niches in vitro
                              Martin J. Hoogduijn, Rotterdam, The Netherlands

11:50                      Engineering functional tissues: The Holy Grail or an attainable goal?
                              Tahera Ansari, Harrow, United Kingdom

12:20                      Pediatric reconstructive transplantation
                              Lawrence Levin, Philadelphia, United States

 

______________________________________________________________________________________________________

VCA in pills:
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This committee brings together 10 representatives of major European teams at the forefront in this field.

Goals:
Our goal is to raise the scientific and clinical development of Vascularized Composite Allotransplantation (VCA) in Europe and to serve as a platform for scientists and clinicians for information and exchange.

 

______________________________________________________________________________________________________

Objectives:

  • Understand the risks and limits of face and upper limb transplantation
  • Discuss and implement new data to characterize chronic rejection
  • Discuss the contribution of animal models in VCA
  • Discuss alternatives strategies  for patients’ management

Target audience:
Surgeons, physicians, researchers, transplant coordinators